MP

Madesh Prakash

Active Director Director DIN 09745315
DIN 09745315 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Madesh Prakash

Data last updated:

Madesh Prakash is a Director at East West Pharma India Private Limited (since 2022). The company operates in Pharma. East West Pharma India Private Limited reported revenue of ₹182 Cr (FY 2025).

DIN 09745315
Primary Designation Director
Industry Pharma
First Appointment 23 Sep 2022
Oldest Company Age 6 yrs
Largest company East West Pharma India Private Limited · ₹182 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20222020₹182 Cr (FY 2025)Active

Board colleagues of Madesh Prakash

Directorship timeline

Open interactive timeline →
East West Pharma India Private Limited
Premium access

Shareholding and investment profile for Madesh Prakash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madesh Prakash

Madesh Prakash currently holds 1 directorship: East West Pharma India Private Limited (Director, since 23 Sep 2022, revenue ₹182 Cr (FY 2025)).

Madesh Prakash was first appointed on 23 Sep 2022 as Director at East West Pharma India Private Limited.

The current boards of Madesh Prakash's companies include Balaraman Mohankumar (East West Pharma India Private Limited), Sabarish Mohankumar (East West Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available